Trailing-twelve-month (TTM) revenue is $4.67 Billion with a year-over-year growth of +65.57%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $840,039,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-04 |
| Q4 FY2025Period ended 2025-12-31 | $1,491,100,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-17 |
| Q1 FY2026Period ended 2026-03-31 | $496,151,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-01 |
| Q2 FY2026Period ended 2026-06-30 | $1,841,424,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-04 |
| TTM revenue | $4,668,714,000 |
Current P/S: $15,230,869,798 market capitalization ÷ $4,668,714,000 TTM revenue = 3.26x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $1.84B.
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 19 comparable quarters.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T20:23:16.573Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20252025-12-31 · USD |
|---|---|
| Expense Reimbursements And Other | $288M |
| Incentive Fees | $49M |
| Management fees | $1.8B |
| Monitoring Fees | $29M |
| Transaction Fees | $231M |
$4.67B
$4.67 Billion
+65.57%
vs. $2.82B a year ago (TTM)
+15.55%
5 Year compound annual growth rate
1 Year
+65.57%
3 Year
+39.98%
5 Year
+15.55%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $4.67B | +$2.04B | +77.91% |
| 2024 | $2.62B | +$767.67M | +41.37% |
| 2023 | $1.86B | +$351.29M | +23.35% |
| 2022 | $1.50B | ($4.08B) | (73.05%) |
| 2021 | $5.58B | +$3.32B | +146.29% |
| 2020 |
TTM Growth
+65.57%
3-Year CAGR
+39.98%
5-Year CAGR
+15.55%
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $2.27B |
| +$111.65M |
| +5.18% |
| 2019 | $2.15B | +$570.45M | +36.01% |
